Valley National Advisers Inc. Buys 15,426 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Valley National Advisers Inc. raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 273.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,072 shares of the exchange traded fund’s stock after buying an additional 15,426 shares during the period. Valley National Advisers Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,999,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Concourse Financial Group Securities Inc. raised its stake in shares of SPDR S&P Biotech ETF by 21.2% in the fourth quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock valued at $59,000 after acquiring an additional 115 shares during the last quarter. Verity Asset Management Inc. raised its stake in shares of SPDR S&P Biotech ETF by 0.8% in the fourth quarter. Verity Asset Management Inc. now owns 17,368 shares of the exchange traded fund’s stock valued at $1,551,000 after acquiring an additional 140 shares during the last quarter. Greenwich Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 1.4% in the fourth quarter. Greenwich Wealth Management LLC now owns 11,451 shares of the exchange traded fund’s stock valued at $1,022,000 after acquiring an additional 155 shares during the last quarter. Mesirow Institutional Investment Management Inc. raised its stake in shares of SPDR S&P Biotech ETF by 3.2% in the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 5,565 shares of the exchange traded fund’s stock valued at $497,000 after acquiring an additional 170 shares during the last quarter. Finally, HB Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 4.9% in the fourth quarter. HB Wealth Management LLC now owns 4,280 shares of the exchange traded fund’s stock valued at $382,000 after acquiring an additional 200 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI traded down $0.49 during trading on Wednesday, reaching $90.87. The stock had a trading volume of 4,676,037 shares, compared to its average volume of 10,621,511. The business’s 50-day moving average price is $90.41 and its 200 day moving average price is $90.94. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The stock has a market capitalization of $6.93 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.